Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2009; 2:689-696, doi:10.1016/j.jcin.2009.04.016
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nasu, K.
Right arrow Articles by Suzuki, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nasu, K.
Right arrow Articles by Suzuki, T.
Related Collections
Right arrowRelated Article

Effect of Fluvastatin on Progression of Coronary Atherosclerotic Plaque Evaluated by Virtual Histology Intravascular Ultrasound

Kenya Nasu, MD*,*, Etsuo Tsuchikane, MD, PhD*, Osamu Katoh, MD*, Nobuyoshi Tanaka, MD*, Masashi Kimura, MD*, Mariko Ehara, MD*, Yoshihisa Kinoshita, MD*, Tetsuo Matsubara, MD*, Hitoshi Matsuo, MD*, Keiko Asakura, MD*, Yasushi Asakura, MD*, Mitsuyasu Terashima, MD*, Tadateru Takayama, MD{dagger}, Junko Honye, MD{dagger}, Atsushi Hirayama, MD{dagger}, Satoshi Saito, MD{dagger}, Takahiko Suzuki, MD, PhD*

* Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan
{dagger} Department of Cardiology, Nihon University Itabashi Hospital, Tokyo, Japan


Figure 1
View larger version (36K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Correlation Between Change in LDL Cholesterol Level and Change in Volume of Each Plaque Component

Change in fibro-fatty volume was significantly correlated with a change in low-density lipoprotein (LDL) cholesterol level as shown in B (p < 0.0001). There was no significant correlation between changes in volume of the other plaque components and change in LDL cholesterol level as shown in A, C, and D.

 

Figure 2
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Correlation Between Change in hsCRP Level and Change in Volume of Each Plaque Component

Change in fibro-fatty volume was significantly correlated with a change in high-sensitivity C-reactive protein (hsCRP) level as shown in B (p = 0.006). There was no significant correlation between changes in volume of the other plaque components and change in hsCRP level as shown in A, C, and D.

 

Figure 3
View larger version (56K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Baseline and 1-Year Follow-Up Gray-Scale and Virtual Histology Intravascular Ultrasound Images Are Presented Side by Side

(A) A representative vessel from the fluvastatin group. Volumetric analyses showed the marked increase of fibrous tissue volume and reduction of fibro-fatty volumes. (B) A representative vessel from the control group. Volumes of all plaque components without fibrous tissue increased during the follow-up period.

 




Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link